What is Lumexa Imaging Holdings, Inc.'s (LMRI) StockRank?

MoatMap's StockRank for Lumexa Imaging Holdings, Inc. (LMRI) is 28/100, with a Sell signal. This is a composite score combining Quality (41), Value (36), and Momentum (40) factor ranks across MoatMap's universe of 25,000+ stocks.

Does Lumexa Imaging Holdings, Inc. have an economic moat?

Lumexa Imaging Holdings, Inc. (LMRI) has a Quality factor score of 41/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Lumexa Imaging Holdings, Inc. a buy, hold, or sell?

MoatMap's current signal for Lumexa Imaging Holdings, Inc. (LMRI) is Sell, based on a StockRank of 28/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.

What sector is Lumexa Imaging Holdings, Inc. in?

Lumexa Imaging Holdings, Inc. (LMRI) operates in the Healthcare sector, specifically the Medical Devices industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

LMRI

SellSinker

Lumexa Imaging Holdings, Inc. · Healthcare · United States · $1.1B · Avg Vol: $5M/d

StockRank

Get insider-trade alerts

P/E (TTM)

—

ROE

-8.0%

D/E

1.6x

Dividend %

—

COMPANY DESCRIPTION

Information for the ticker LMRI and company name 'Lumexa Imaging Holdings, Inc.' as a publicly traded entity is not readily available on major exchanges or widely recognized financial data providers. It may refer to a private entity, a delisted stock, or a ticker associated with a different company or financial instrument not in public circulation.

FINANCIAL SUMMARY (USD)

Year	2023	2024	2025	CAGR	TTM	2026E	2027E	Fwd CAGR
Revenue	935.9M	948.9M	1.0B	4.6%	1.0B	1.1B	1.1B	4.8%
EPS	-1.76	-1.35	-0.66	—	-0.29	—	—	—
Shares	94.6M	94.6M	96.1M	+1.6%	96.1M	—	—	—
Debt	1.3B	1.3B	962.5M	-14.1%	975.4M	—	—	—
Equity	198.4M	161.7M	586.1M	71.9%	—	—	—	—
Op CF	37.5M	40.7M	17.1M	-32.5%	64.7M	—	—	—
Inv CF	-29.7M	-22.3M	-21.0M	—	—	—	—	—
Fin CF	-8.8M	-12.5M	36.6M	—	—	—	—	—

Loading 1Y...

PRICE (1Y)+9.5%

SMA 50SMA 200

$11.28

RSI (14)

42.7

SCORE BREAKDOWN

Quality

ROIC

5.4%56.7

ROE

-8.0%37.0

GP/Assets

8.8%23.5

Op. Margin

3.2%48.3

FCF/Assets

-0.4%44.0

Piotroski

783.9

Int. Cover

0.7x38.1

D/E Ratio

1.59x7.7

Current Ratio

1.44x24.7

Value

P/E (TTM)

—N/A

EV/EBITDA

26.6x23.9

P/FCF

—N/A

P/B

1.9x64.9

P/S

1.1x81.8

Div Yield

—N/A

Momentum

52W High %

—N/A

RS 6M

-35%23.8

SMA 50/200

—N/A

EPS Rev 4W

+1.1%48.7

EPS Rev 12W

+1.8%64.8

EPS Improve

+414%94.9

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$1.1B

P/E (Forward)

13.4x

Gross Margin

14.8%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of LMRI are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
LMRI	Lumexa Imaging Holdings, Inc.(you)	$1.1B	28	Sell
QDEL	QuidelOrtho Corporation	$1.0B	29	Sell
CBLL	CeriBell, Inc.	$911M	27	Sell
BBNX	Beta Bionics, Inc.	$887M	27	Sell
ATEC	Alphatec Holdings, Inc.	$1.5B	27	Sell
TNDM	Tandem Diabetes Care, Inc.	$1.5B	31	Sell
AORT	Artivion, Inc.	$1.3B	36	Hold
PRCT	PROCEPT BioRobotics Corporation	$1.2B	15	Strong Sell
CTKB	Cytek Biosciences, Inc.	$608M	32	Sell
SENS	Senseonics Holdings, Inc.	$493M	29	Sell

Peer medians: ROE -30.8% · P/E 27.0x · Gross margin 58.3%

Lumexa Imaging Holdings, Inc. (LMRI): Stock Score Summary

Lumexa Imaging Holdings, Inc. (LMRI) has a MoatMap StockRank of 28/100 based on Quality (41/100), Value (36/100), and Momentum (40/100) factor scores. The current signal is SELL.

Key Financial Metrics

Price	$11.28
Market Cap	$1.1B
P/E (Forward)	13.38
Price/Book	1.90
Return on Equity	-8.0%
Return on Invested Capital	5.4%
Debt/Equity	1.59x
Gross Margin	14.8%
Operating Margin	3.2%
Revenue Growth	5.1%
Free Cash Flow	$-6M

Lumexa Imaging Holdings, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Lumexa Imaging Holdings, Inc.’s (LMRI) StockRank?: MoatMap’s StockRank for Lumexa Imaging Holdings, Inc. (LMRI) is 28/100, with a Sell signal. It is a composite of Quality (41), Value (36), and Momentum (40) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does Lumexa Imaging Holdings, Inc. have an economic moat?: Lumexa Imaging Holdings, Inc. (LMRI) has a Quality factor score of 41/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Lumexa Imaging Holdings, Inc. a buy, hold, or sell?: MoatMap’s current signal for Lumexa Imaging Holdings, Inc. (LMRI) is Sell, based on a StockRank of 28/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Lumexa Imaging Holdings, Inc. in?: Lumexa Imaging Holdings, Inc. (LMRI) operates in the Healthcare sector, specifically the Medical Devices industry (United States).